Track key indicators & trends
Get your questions answered
Stay informed, get engaged
Grow your business
Driving change & making a difference
Press releases and contact information
Everything you need to grow
News, resources to build your team
The 2026 General Assembly session was one of the least contentious in recent memory for the biopharma sector. Bills calling for innovation-sapping price controls and unworkable programs…
The Connecticut Science Center is home to exhibits, programs, and…
The Connecticut General Assembly is exploring ways to address rising…
The COVID-19 pandemic has given us new insights into...
There’s business confidence—and then there’s Pfizer. Last March, with...
The Lamont administration is proposing legislation codifying the new...
Angela Hwang, group president of Pfizer Biopharmaceuticals Group, is the...
When scientists from The Jackson Laboratory sent genetically modified...
CBIA BizCast talks with Arvinas CEO John Houston about...
People, events, technology—all can be disruptors. Certainly the novel coronavirus...
The following letter by Pfizer chair and CEO Albert...
The ongoing coronavirus pandemic is a cause of much...
The latest news and information delivered directly to your inbox.
CBIA IS FIGHTING TO MAKE CONNECTICUT A TOP STATE FOR BUSINESS, JOBS, AND ECONOMIC GROWTH. A BETTER BUSINESS CLIMATE MEANS A BRIGHTER FUTURE FOR EVERYONE.